Production (Stage)
Verrica Pharmaceuticals Inc.
VRCA
$0.6117
-$0.0083-1.34%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 39.87% | 29.13% | -33.02% | 15.47% | 17.40% |
| Total Depreciation and Amortization | -17.79% | -26.02% | 2.40% | -1.76% | 56.68% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -63.71% | 35.24% | 1.91% | 12.92% | -49.13% |
| Change in Net Operating Assets | -12.10% | -137.12% | 560.90% | 4.78% | -151.59% |
| Cash from Operations | 21.08% | -87.71% | 47.68% | 17.99% | -37.50% |
| Capital Expenditure | -- | 100.00% | -45.45% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 150.00% | -45.45% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -984.76% | -72.35% | -22.60% | -13.46% | -578.26% |
| Issuance of Common Stock | -- | -- | -100.00% | 3,650.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 190.00% | 70.64% | -20.43% | -16,866.67% |
| Cash from Financing | -110.29% | 10,030.98% | 37.97% | 3.18% | -2,348.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -171.60% | 360.51% | 47.26% | 17.46% | -39.61% |